Prostate cancer in the Arab world: Bibliometric review and research priority recommendations.

Arab region Prostate cancer bibliometrics oncology screening urology

Journal

Arab journal of urology
ISSN: 2090-598X
Titre abrégé: Arab J Urol
Pays: United States
ID NLM: 101562480

Informations de publication

Date de publication:
2022
Historique:
entrez: 9 5 2022
pubmed: 10 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

To conduct a scoping review examining the status of prostate cancer research in Arab countries and systematically map publications across the cancer care pathway. Prostate cancer incidence has been rising in the Arab world and tackling its increasing burden will require evidence-based policies. We searched Medline, PubMed and Scopus for peer-reviewed publications related to both our research topic and countries of interest by using controlled vocabulary and keywords. Search results were limited for the period between 2000 and 2020, screened for duplicates, and then included in our study based on pre-specified eligibility criteria. We used a structured data extraction form to extract information related to the article, its methodology, its cancer care pathway, funding status, and authorship. A total of 4142 publications were retrieved from our search, of which 874 articles remained after applying eligibility criteria. Trends show a steady increase in prostate cancer research in the Arab world. Most studies were focussed on diagnosis and treatment, whereas a lack in studies concerning screening and prevention, as well as epidemiological data, was evident. Most studies were not funded and had no female author. Country gross domestic product and population were positively correlated with its research output. The USA had the highest number of corresponding authors. The majority of Arab-based studies did not involve collaborations with other countries. Most research conducted was basic or clinical studies with a low level of evidence. Our present review identified significant gaps and limitations in prostate cancer research in Arab countries. Priority areas for research investment have also been highlighted as a first step towards context-specific health policies. ASR: age-standardised rate; COVID-19: coronavirus disease 2019; GDP: gross domestic product; HDI: Human Development Index; KSA: Kingdom of Saudi Arabia; UAE: United Arab Emirates.

Identifiants

pubmed: 35530565
doi: 10.1080/2090598X.2021.2024984
pii: 2024984
pmc: PMC9067956
doi:

Types de publication

Journal Article

Langues

eng

Pagination

81-87

Informations de copyright

© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Déclaration de conflit d'intérêts

No potential conflict of interest was reported by the author(s).

Références

Pharmacotherapy. 2006 Jun;26(6):759-67
pubmed: 16716129
PLoS One. 2020 May 13;15(5):e0232458
pubmed: 32401823
BMC Womens Health. 2015;15:25
pubmed: 25783656
J Glob Health. 2019 Jun;9(1):010402
pubmed: 30410745
Nature. 2004 Jul 15;430(6997):311-6
pubmed: 15254529
Handb Exp Pharmacol. 2020;257:383-398
pubmed: 31628602
Int J Cancer. 2016 Mar 15;138(6):1388-400
pubmed: 26488767
J Glob Health. 2018 Dec;8(2):020411
pubmed: 30410737
Clin Genitourin Cancer. 2015 Dec;13(6):505-11
pubmed: 26149392
Asian Pac J Cancer Prev. 2007 Jul-Sep;8(3):405-11
pubmed: 18159978
Minn Med. 2010 Aug;93(8):39-44
pubmed: 20862878
Urology. 2021 Apr;150:72-76
pubmed: 32512106
Front Public Health. 2020 May 19;8:209
pubmed: 32574298
Epidemiol Rev. 2000;22(1):145-54
pubmed: 10939021
World J Urol. 2020 Mar;38(3):681-693
pubmed: 31297628
Ecancermedicalscience. 2020 Oct 29;14:1129
pubmed: 33209120
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
JCO Glob Oncol. 2021 Jul;7:1101-1109
pubmed: 34236931
Lancet. 2014 Jan 25;383(9914):343-55
pubmed: 24452043

Auteurs

Adel Hajj Ali (AH)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Hussein Awada (H)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Hasan Nassereldine (H)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Mohammad Zeineddine (M)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Zahy Abdul Sater (ZA)

Global Health Institute, American University of Beirut, Beirut, Lebanon.

Albert El-Hajj (A)

Division of Urology, American University of Beirut Medical Center, Beirut, Lebanon.

Deborah Mukherji (D)

Division of Hematology-Oncology, American University of Beirut Medical Center, Beirut, Lebanon.

Classifications MeSH